HedgeChatter

  • Home /
  • Tag Archives

CYTK

Cytokinetics to Announce First Quarter Results on April 30, 2013

[at noodls] – South San Francisco, CA – April 16, 2013 Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report first quarter results on Tuesday, April 30, 2013 at 4:00 PM Eastern Time. … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click […]

April 16, 2013 Bystocknews , Comments Off on Cytokinetics to Announce First Quarter Results on April 30, 2013 read more

Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv

[at noodls] – Award to Support Testing of Tirasemtiv in Mouse Models of Spinal Muscular Atrophy South San Francisco, CA, and Elk Grove Village, IL – April 4, 2013 South San Francisco, CA, and Elk Grove Village, IL, … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring […]

April 4, 2013 Bystocknews , Comments Off on Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv read more

Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107

[at noodls] – Second Drug Candidate from Cytokinetics’ Fast Skeletal Muscle Activator Program Begins Clinical Trial in Expanded Development Program South San Francisco, CA – April 1, 2013 Cytokinetics, Incorporated … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click here to view […]

April 1, 2013 Bystocknews , Comments Off on Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107 read more

Cytokinetics to Present at Upcoming Healthcare Conferences

[at noodls] – South San Francisco, CA – March 29, 2013 Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click here to view […]

March 29, 2013 Bystocknews , Comments Off on Cytokinetics to Present at Upcoming Healthcare Conferences read more

Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis

[at noodls] – Positive Results from Evidence of Effect Trial Inform Translation of Novel Mechanism of Action South San Francisco, CA – March 21, 2013 Cytokinetics, Incorporated (Nasdaq: CYTK) announced the presentation … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click here to view […]

March 21, 2013 Bystocknews , Comments Off on Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis read more

Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis

[at noodls] – Phase IIa data to be Presented at the 65th Annual Meeting of the American Academy of Neurology South San Francisco, CA – March 13, 2013 Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that an … moreView todays social media effects on CYTKView the latest stocks trending across Twitter. Click to view dashboardSee who Cytokinetics is hiring next, click […]

March 13, 2013 Bystocknews , Comments Off on Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis read more